PTC Therapeutics: Breakthrough in Rare Diseases Secures Record Revenue

PTC Therapeutics is a leading biopharmaceutical company focused on the development and marketing of therapies for rare genetic diseases, enabling stable revenues through already approved products and attractive market prices. The recent quarterly results showed a significant revenue jump and successful market acceptance of the new drug Sephience, which, along with Evrysdi royalty revenues, is an important driver for future growth. These developments helped to refine the revenue forecast for 2025 to $750-800 million. PTC Therapeutics...